Home › Funds › SECTORAL ASSET MANAGEMENT INC › ALNY
SECTORAL ASSET MANAGEMENT INC position in ALNY
ALNYLAM PHARMACEUTICALS INC · Health Care
SECTORAL ASSET MANAGEMENT INC reported holding 7,385 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 1.36% of its reported portfolio and ranking #32 among its reported holdings. SECTORAL ASSET MANAGEMENT INC has disclosed ALNY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SECTORAL ASSET MANAGEMENT INC's ALNY position evolved
SECTORAL ASSET MANAGEMENT INC first disclosed a stake in ALNY in Q3 2023 at 28,960 shares (US$5.1M). Across 13 filings, SECTORAL ASSET MANAGEMENT INC increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 7,385 shares valued at US$1.8M — an increase of 5,075 shares quarter over quarter.. Notable position changes include a 37% trim in Q1 2025 (shares rose 20% over the following quarter), a 36% trim in Q2 2025 (shares rose 40% over the following quarter), a 220% increase in Q3 2026 (shares fell 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 28.96K | $5.13M | New |
| Q4 2023 | 22.64K | $4.33M | Reduce |
| Q1 2024 | 18.46K | $2.76M | Reduce |
| Q2 2024 | 12.48K | $3.03M | Reduce |
| Q3 2024 | 9.69K | $2.67M | Reduce |
| Q4 2024 | 8.30K | $1.95M | Reduce |
| Q1 2025 | 5.21K | $1.41M | Reduce |
| Q2 2025 | 3.32K | $1.08M | Reduce |
| Q3 2025 | 3.27K | $1.49M | Reduce |
| Q4 2025 | 2.99K | $1.19M | Reduce |
| Q1 2026 | 2.31K | $864.23K | Reduce |
| Q2 2026 | 2.31K | $695.38K | Hold |
| Q3 2026 | 7.38K | $1.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALNY and 13F data
ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 30 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$1.36B), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALNY
- T. Rowe Price Investment Management, Inc. 5.64M sh · $1.70B · Q2 2026
- Baillie Gifford & Co 5.49M sh · $1.36B · Q3 2026
- Orbis Allan Gray Ltd 1.99M sh · $598.27M · Q2 2026
- Two Sigma Investments 1.88M sh · $564.71M · Q2 2026
- TWO SIGMA ADVISERS, LP 1.13M sh · $450.36M · Q4 2025
- Deep Track Capital, LP 825.00K sh · $248.35M · Q2 2026
More on SECTORAL ASSET MANAGEMENT INC
FAQ
How long has SECTORAL ASSET MANAGEMENT INC held ALNY?
SECTORAL ASSET MANAGEMENT INC has disclosed ALNY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SECTORAL ASSET MANAGEMENT INC's current position in ALNY?
As of Q3 2026, SECTORAL ASSET MANAGEMENT INC holds 7.38K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $1.82M, representing 1.36% of its reported portfolio and ranking #32.
Has SECTORAL ASSET MANAGEMENT INC been buying or selling ALNY?
In the latest 13F filing (Q3 2026), SECTORAL ASSET MANAGEMENT INC increased its position in ALNY.
Which other funds hold ALNY?
Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.